Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Granules India
Pharma
Granules receives Form 483 over poor document controls and more
From truckloads of torn documents to avian incursions, Granules' new manufacturing reprimand from the FDA is alarming no matter which way you read it.
Fraiser Kansteiner
Sep 19, 2024 10:11am
FDA issues Granules India 3 observations after inspection
Jan 31, 2022 10:20am
Marksans dramatically expands metformin recall on NDMA scare
Oct 5, 2020 6:18pm
Sun Pharma recalls metformin after carcinogen test
Sep 23, 2020 10:45am
Belgium's Ajinomoto builds new Indian small-molecule facility
Aug 13, 2020 8:00am
FiercePharmaAsia—Gardasil, Lupin, CANbridge and more
May 26, 2017 9:11am
